Trademark: 97171264
Word
HIF-SNRNASEQ
Status Date
Friday, March 29, 2024
Filing Date
Tuesday, December 14, 2021
Published for Opposition
Tuesday, August 8, 2023
42 Research and development of pharmaceuticals for the treatment of neurodegenerative diseases, brain cancer, and brain tumors; providing information about medical research in the field of neurodegenerative diseases, brain cancer, and tumors; research and development in the pharmaceutical and biotechnology fields; Research and development services in the fields of custom chemistry, DNA sequencing and quantification, assay design, testing and analysis, bioinfomatics and biological data analysis, and biological image processing and data extraction, and consultation services related thereto
HIF SINGLE NUCLEUS RNA SEQUENCING, SINGLE NUCLEI RNA SEQUENCING
Sep 13, 2022
Notification Of Non-Final Action E-Mailed
Dec 17, 2021
New Application Entered
Dec 17, 2021
New Application Office Supplied Data Entered
Sep 3, 2022
Assigned To Examiner
Sep 13, 2022
Non-Final Action Written
Sep 13, 2022
Non-Final Action E-Mailed
Mar 6, 2023
Teas Response To Office Action Received
Jul 3, 2023
Assigned To Lie
Jul 3, 2023
Correspondence Received In Law Office
Jul 3, 2023
Teas/Email Correspondence Entered
Jul 6, 2023
Approved For Pub - Principal Register
Jul 19, 2023
Notification Of Notice Of Publication E-Mailed
Aug 8, 2023
Official Gazette Publication Confirmation E-Mailed
Aug 8, 2023
Published For Opposition
Mar 29, 2024
Sou Extension 1 Granted
Mar 29, 2024
Sou Teas Extension Received
Mar 29, 2024
Sou Extension 1 Filed
Oct 3, 2023
Noa E-Mailed - Sou Required From Applicant
Mar 30, 2024
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
